Alternatives to gemfibrozil
FDA shortage status is active for gemfibrozil; 1 same-class SPL records are listed below for registry comparison only.
Brand: Lopid
gemfibrozil class peers while FDA lists an active shortage
gemfibrozil (Lopid) is on an FDA shortage listing while 1 other Fibrate SPL records remain in this registry peer set (class inventory 2). Labeled indication field for gemfibrozil: This medicine is used to treat very high triglyceride levels in adults when diet alone doesn't work.
Top FAERS reaction fields for gemfibrozil total 6,666 reports across 10 reactions, set beside fenofibrate. Counts are exposure-weighted submissions, not per-patient risk.
About gemfibrozil
Gemfibrozil is a medicine that helps lower high triglyceride levels in your blood. It can also help reduce the risk of heart disease in some people.
Used for: This medicine is used to treat very high triglyceride levels in adults when diet alone doesn't work. High triglycerides can increase your risk of pancreatitis. Gemfibrozil can also lower the risk of heart disease in some people with specific cholesterol problems.
1 Fibrate peers (wide set)
gemfibrozil vs fenofibrate · FAERS reaction fields
FAERS top-reaction field "Nausea" shows the widest count spread between gemfibrozil and fenofibrate in this extract (2,029-report gap on that field). Counts are exposure-weighted submissions, not prevalence rates.
| Side Effect | gemfibrozil | fenofibrate |
|---|---|---|
| Nausea | 883 | 2,912 |
| Fatigue | 825 | 2,840 |
| Diarrhoea | 726 | 2,681 |
| Pain | 693 | 1,955 |
| Dizziness | 617 | 1,962 |
| Rhabdomyolysis | 604 | - |
| Dyspnoea | 599 | 2,099 |
| Asthenia | 598 | 1,826 |
"-" means no reports for that reaction. Report counts reflect total FAERS submissions, not prevalence rates.
gemfibrozil shortage vs Fibrate peer index
Shortage status
FDA shortage listing is active for gemfibrozil (status: To Be Discontinued). Peer rows remain a registry index, not a switch guide.
Frequently Asked Questions
Does FDA list a shortage for gemfibrozil while peers remain indexed? ▼
Registry note: Shortage listings and peer indexes are for registry orientation only. This information is for educational purposes only and is not a substitute for professional medical advice. Do not stop or change your medication without talking to your doctor or pharmacist.
Field note for gemfibrozil: see also the generic vs brand label guide when reading Lopid SPL strings.
Read our methodology - how this data is sourced, computed, and verified.